ADAM8 and neoplasm: A profound decrease in the numbers of CTCs was observed with ADAM8 KD (12.8 ± 7.0 versus 0.0 ± 2.0/μl of blood) (Fig 4G), suggesting that ADAM8 might be involved in dissemination of CTCs; although the possibility that this relates to the large difference in tumor burden could not be excluded.